Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC23495 DBIBB
A potent and specific, nonlipid agonist of LPA2 receptor with EC50 of 100 nM, without activating or inhibiting LPA1/3/4/5 receptors.
More description
DC22432 CCX2553
A potent and specific CCR6 antagonist.
More description
DC23392 RX-37
A potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM for BD1 and BD2 domains of BRD2, BRD3, and BRD4.
More description
DC23843 BMS-935177
A potent and selective, orally bioavailable, reversible BTK inhibitor with IC50 of 2.8 nM.
More description
DC21004 EXEL-8232
A potent and selective, orally bioavailable JAK2 inhibitor with IC50 of 2 nM.
More description
DC20888 Fadrozole
A potent and selective, orally bioavailable aromatase inhibitor with IC50 of 1.7 nM, 180 times more potent than aminoglutethimide.
More description
DC22802 MK2-IN-28
A potent and selective, non-ATP competitive, allosteric MAPKAPK2/3 (MK2/3) inhibitor with IC50 of 8 nM for MK2, hTNFα EC50 of 0.31 uM.
More description
DC22978 PF-04471141 hydrochloride
A potent and selective, CNS-penetrant PDE1 inhibitor with IC50 of 35 nM for PDE1B..
More description
DC22979 PF-04822163
A potent and selective, CNS-penetrant PDE1 inhibitor with IC50 of 2.4 nM for PDE1B..
More description
DC23521 VU 6010572
A potent and selective, CNS penetrant mGlu3 negative allosteric modulator with IC50 of 245 nM.
More description
DC23520 VU 6001966
A potent and selective, CNS penetrant mGlu2 negative allosteric modulator with IC50 of 78 nM.
More description
DC11670 MK-4409
A potent and selective, brain penetrant FAAH inhibitor with IC50 of 11 nM.
More description
DC22885 TAN-67 dihydrobromide
A potent and selective δ-opioid receptor agonist that has high affinity and selectivity for the δ1 subtype with Ki of 1.12 nM.
More description
DC20627 ABT 089 dihydrochloride
A potent and selective α4β2 nAChR agonist with Ki of 16 nM.
More description
DC11984 AMG 8379
A potent and selective voltage-gated sodium channel Nav1.7 antaognist with IC50 of 8.5 nM.
More description
DC25087 Vandetanib trifluoroacetate
A potent and selective VEGFR2 (KDR) inhibitor with IC50 of 40 nM.
More description
DC23839 IN-1233 phosphate
A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery..
More description
DC23840 IN-1233
A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery..
More description
DC22715 RP-67580
A potent and selective tachykinin NK1 receptor antagonist with Ki of 2.9 nM.
More description
DC24175 A-770041
A potent and selective small-molecule inhibitor of Lck with IC50 of 147 nM.
More description
DC22341 H-1152
A potent and selective ROCK inhibitor with Ki of 1.6 nM.
More description
DC26074 CD 1530
A potent and selective RARγ receptor agonist with Ki of 150 nM.
More description
DC22968 TC-E 5005
A potent and selective PDE10A inhibitor with IC50 of 7.28 nM.
More description
DC22970 BMS 843496
A potent and selective PDE10A inhibitor with binding affinity (Kd) of 0.15 nM, IC50 of 2.11 nM.
More description
DC22671 Saredutant
A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor.
More description
DC20474 Nek2 inhibitor (R)-21
A potent and selective NIMA-related Kinase 2 (NEK2) inhibitor with IC50 of 22 nM, >200-fold selectivity over Plk1, Mps1, Aurora A and CDK2.
More description
DC23966 mTOR-IN-1
A potent and selective mTOR inhibitor with Ki of 1.5 nM.
More description
DC22887 THIQ
A potent and selective melanocortin 4 receptor (MC4R) agonist with EC50 of 2.1 nM.
More description
DC23410 BI 186908
A potent and selective MCH-R1 antagonist with IC50 of 22 nM, Ki of 14 nM.
More description
DC22707 Ibodutant
A potent and selective linear tachykinin NK2 receptor antagonist with pKb of 9.3.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X